|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years显示文摘 | Mark R Nelson Christine Katlama Julio S Montaner David A Cooper Brian Gazzard Bonaventura Clotet Adriano Lazzarin Knud Schewe Joep Lange Christina Wyatt Sue Curtis Shan-Shan Chen Stephen Smith Norbert Bischofberger James F Rooney | 2007 | AIDS2007，，10： | 2 |
| 2 | Soil moisture: A central and unifying theme in physical geography显示文摘 | Legates David R Mahmood Rezaul Levia Delphis F DeLiberty Tracy L Quiring Steven M Houser Chris Nelson Frederick E | 2011 | Progress in Physical Geography2011，，1： | 2 |
| 3 | The growth of patenting and licensing by U.S. universities: an assessment of the effects of the Bayh–Dole act of 1980显示文摘 | David C Mowery Richard R Nelson Bhaven N Sampat Arvids A Ziedonis | 2001 | Research Policy2001，，1： | 1 |
| 4 | Spatial variability of the CO 2 sink in the Sargasso Sea显示文摘 | Norman B Nelson Nicholas R Bates David A Siegel Anthony F Michaels | 2001 | Deep-Sea Research Part II2001，，8： | 1 |
| 5 | Activation of Tumor Necrosis Factor-a system in chronic Hepatitic C virus infection显示文摘 | David R Nelson Herbert L | 1997 | Digestive Diseases and Sciences1997，42，： | 1 |
| 6 | Increased sperm nuclear DNA damage in normozoospermic infertile men: a prospective study显示文摘 | Ramadan A Saleh Ashok Agarwal David R Nelson Essam A Nada Mohammed H El-Tonsy Juan G Alvarez Anthony J Thomas Rakesh K Sharma | 2002 | Fertility and Sterility2002，，2： | 1 |
| 7 | The cross-scale interplay between social and biophysical context and the vulnerability of irrigation-dependent societies:archaeology's long-term perspeetive显示文摘 | Nelson Margaret C Kintigh Keith Abbott David R | 2010 | Ecology and Society2010，15，3： | 1 |
| 8 | Structure of the cross-β spine of amyloid-like fibrils显示文摘 | David Eisenberg Rebeca Nelson Michael R Sawaya | 2005 | Nature2005，435，： | 1 |
| 9 | How should we measure and report radiotherapy-induced xerostomia?显示文摘 | AVRAHAM E NELSON R DAVID R | 2003 | Sem Rad Onc2003，13，3： | 1 |
| 10 | Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score显示文摘 | Kumar Shaji K Gertz Morie A Lacy Martha Q Dingli David Hayman Suzanne R Buadi Francis K Short-Detweiler Kristen Zeldenrust Steven R Leung Nelson Greipp Philip R Lust John A Russell Stephen J Kyle Robert A Rajkumar S Vincent Dispenzieri Ange | 2011 | Mayo Clinic Proceedings2011，，1： | 1 |
| 11 | Activation of Tumor Necrosis Factor-α system in Chronic Hepatitis C Virus Infection显示文摘 | David R Nelson MD Herbert L | 1997 | Digestive Diseases and Sciences1997，42，12： | 1 |
| 12 | Thymine-thymine dimer bypass by DNA polymerase ζ显示文摘 | Christopher W Lawence David C Hin-kle | 1996 | Science1996，272，： | 1 |
| 13 | In Vivo Assay of Folate Receptors in Nonfunctional Pituitary Adenomas with ^sup 99m^Tc-Folate SPECT/CT显示文摘 | Galt James R Halkar Raghuveer K Evans Chheng-Orn Osman Naema A LaBorde David Fox Timothy H Faraj Bajat A Kumar Kush Wang Houping Oyesiku Nelson M | 2010 | The Journal of Nuclear Medicine2010，，： | 1 |
| 14 | Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial显示文摘 | Eric Lawitz Jay P Lalezari Tarek Hassanein Kris V Kowdley Fred F Poordad Aasim M Sheikh Nezam H Afdhal David E Bernstein Edwin DeJesus Bradley Freilich David R Nelson Douglas T Dieterich Ira M Jacobson Donald Jensen Gary A Abrams Jama M Darling Maribel Ro | 2013 | The Lancet Infectious Diseases2013，，5： | 1 |
| 15 | Cytochromr P450 and the individuality of spe- cies显示文摘 | David R Nelson | 1999 | Arch Bioehem Biophys1999，369，1： | 1 |
| 16 | Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial显示文摘 | Eric Lawitz Jay P Lalezari Tarek Hassanein Kris V Kowdley Fred F Poordad Aasim M Sheikh Nezam H Afdhal David E Bernstein Edwin DeJesus Bradley Freilich David R Nelson Douglas T Dieterich Ira M Jacobson Donald Jensen Gary A Abrams Jama M Darling Maribel Ro | 2013 | The Lancet Infectious Diseases2013，，5： | 1 |
| 17 | Selective and Functional 5 - hydroxytryptamine 3 Receptor Antagonism by BRL 43694 (granisetmn) 显示文摘 | Gareth J Sanger David R Nelson | 1989 | European Journal of Pharmacology1989，159，： | 1 |
| 18 | Comparison of Complication Rates Between Hemiarthroplasty and Total Hip Arthroplasty for Intracapsular Hip Fractures显示文摘 | SooHoo Nelson F Farng Eugene Chambers Lauchlan Znigmond David S Lieberman Jay R | 2013 | Orthopedics (Online)2013，，4： | 1 |
| 19 | Seminal oxidative stress in patients with chronic prostatitis显示文摘 | Fabio F Pasqualotto Rakesh K Sharma Jeannette M Potts David R Nelson Anthony J Thomas Ashok Agarwal | 2000 | Urology2000，，6： | 1 |
| 20 | Consent2Share:an integrated broad consenting process for re-contacting potential study subjects显示文摘Background and Aim:Obtaining sufficient subjects into research studies is an ongoing barrier to conducting clinical research.Privacy rules add to the complexity of identifying qualified study subjects.The process described facilitates consent of patients coming to their clinically scheduled appointments who are asked to consent to having researchers review their electronic medical records(EHR),and if they meet study criteria for future research,being contacted by those researchers and asked if they wish to be involved in a research project.Methods:An interdisciplinary group representing the Institutional Review Board(IRB),Information Technology(IT),Hospital,University and Research developed an initial paper then electronic method to consent all patients attending a medical subspecialty clinic.All consent data are integrated to the EHR to facilitate linking to clinical information.Results:Although the paper consenting method resulted in over an 80%“yes”rate of consent,it was complicated by significant procedural challenges which prevented scalability.Revising the process has resulted in nearly 28,000 patients consenting in a 3 year period and in 20 IRB approved protocols using subjects who agreed to Consent2Share.Conclusions:A multi-disciplinary effort is essential to develop a successful electronic based,integrated process to assist investigators and patients to facilitate study subject accrual.Relevance for patients:Consent2Share more efficiently assists researchers in identifying and contacting potential study subjects that meet entrance criteria.The process provides a model to comply with the proposed Notice of Public Rule Making(NPRM)where institutions will be strongly encouraged to develop broad research consent procedures. | R Peter Iafrate Gloria P Lipori Christopher A Harle David R Nelson Timothy J Barnash Patricia T Leebove Kathleen A Adams Debbi Montgomery | 2016 | Journal of Clinical & Translational Research2016，2，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员